Group 1 - A new investment fund named Tianjin Haihe Venture Capital Fund Partnership has been established with a capital contribution of approximately 700 million yuan [1] - The fund's business scope includes private equity investment, investment management, and asset management activities [1] - The fund is co-funded by Jiuan Medical (002432) among other contributors [1]

Group 1 - Tianjin Haihe Venture Capital Fund Partnership (Limited Partnership) has been established with a total investment of 701 million RMB [1] - The fund's operational scope includes private equity investment, investment management, asset management, and venture capital activities [1] - The fund is jointly funded by Tianjin Baifu Haihe West Coast Private Fund Partnership (Limited Partnership), Tianjin Binhai Industrial Development Fund Partnership (Limited Partnership), and Jiuan Medical (002432) [1] Group 2 - The fund is managed by Tianjin Haihe Industrial Fund Management Co., Ltd. [2] - The fund is registered with the Tianjin Hexi District Market Supervision Administration [2] - The fund's business activities are subject to registration with the Asset Management Association of China before commencing operations [2]

Core Insights - A new private equity fund named Tianjin Haihe Venture Capital Fund Partnership (Limited Partnership) was established on November 3, with a total investment of 701 million RMB [1] Group 1 - The fund is managed by Tianjin Haihe Industry Fund Management Co., Ltd., focusing on private equity investments, investment management, asset management, and venture capital activities [1] - The partners of the fund include Tianjin Baifu Haihe West Coast Private Equity Fund Partnership (Limited Partnership), Tianjin Binhai Industry Development Fund Partnership (Limited Partnership), and Jiuan Medical (002432) among others [1]

Core Viewpoint - The establishment of Tianjin Haihe Venture Capital Fund Partnership (Limited Partnership) indicates a growing interest in private equity investments and venture capital in the Tianjin region, with a significant capital commitment of 701 million RMB [1] Group 1: Fund Details - The fund is managed by Tianjin Haihe Industry Fund Management Co., Ltd., focusing on private equity investments, investment management, asset management, and venture capital activities [1] - The total capital contribution to the fund amounts to 701 million RMB, highlighting a substantial financial commitment [1] Group 2: Partners Involved - The fund's partners include Tianjin Baifu Haihe West Coast Private Fund Partnership (Limited Partnership), Tianjin Binhai Industry Development Fund Partnership (Limited Partnership), and Jiuan Medical (002432), showcasing a diverse group of investors [1]

Group 1 - The core point of the article is that Jiuan Medical announced a share buyback plan, having repurchased a total of 8,541,001 shares, which represents 1.84% of the company's total share capital as of October 31, 2025 [1]

Core Viewpoint - Jiuan Medical (002432.SZ) has announced a share buyback program, reflecting the company's commitment to enhancing shareholder value through strategic capital management [1] Summary by Categories Share Buyback Details - As of October 31, 2025, the company has repurchased a total of 8,541,001 shares, which represents 1.84% of the current total share capital [1] - The highest transaction price during the buyback was 40.883 CNY per share, while the lowest was 39.69 CNY per share [1] - The total amount paid for the buyback was approximately 342.86 million CNY, excluding transaction fees [1] Compliance and Strategy - The buyback is in accordance with relevant laws and regulations, aligning with the company's established share repurchase plan [1]

Core Viewpoint - Jiuan Medical (002432.SZ) announced a share buyback plan, indicating a strategic move to enhance shareholder value and confidence in the company's future prospects [1] Group 1 - The company has repurchased a total of 8.541 million shares, which represents 1.84% of its current total share capital [1] - The total amount paid for the share buyback is 343 million yuan, excluding transaction fees [1] - The buyback is set to be completed by October 31, 2025, through a centralized bidding method [1]

Core Viewpoint - Jiuan Medical (002432.SZ) announced a share buyback plan, indicating a strategic move to enhance shareholder value and confidence in the company's future prospects [1] Summary by Categories Company Actions - The company has repurchased a total of 8.541 million shares, which represents 1.84% of its current total share capital [1] - The total amount spent on the share buyback is 343 million yuan, excluding transaction fees [1]

证券代码：002432 证券简称：九安医疗 公告编号：2025-088 天津九安医疗电子股份有限公司 关于回购公司股份的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确和 完整，没有虚假记载、误导性陈述或重大遗漏。 天津九安医疗电子股份有限公司（以下简称"公司"）于2025年10月13日召 开了第六届董事会第二十七次会议，审议并通过了《关于公司回购股份方案的议 案》。本次回购资金来源为公司自有资金及回购专项贷资金，回购的资金总额不 低于3亿元人民币（含）且不超过6亿元人民币（含），回购股份的价格为不超过 人民币53.5元/股（含），具体回购数量以回购期限届满时实际回购的股份数量为 准。具体回购方案详见公司2025年10月14日在《证券时报》和巨潮资讯网 （http://www.cninfo.com.cn）披露的《关于回购公司股份方案暨取得股票回购专 项贷款承诺函的公告》（公告编号：2025-075）。 根据《上市公司股份回购规则》《深圳证券交易所上市公司自律监管指引第 9号—回购股份》等相关规定，公司在回购期间应当在每个月的前3个交易日内公 告截至上月末的回购进展情况。现将公司回购股份进展情况公告 ...

Group 1 - The Tianjin Free Trade Zone concept declined by 2.70%, ranking among the top declines in the concept sector, with companies like Saixiang Technology hitting the limit down [1] - Major stocks within the Tianjin Free Trade Zone concept that experienced significant declines include HNA Technology, Jintou City Development, and Bohai Chemical [1] - The net outflow of main funds from the Tianjin Free Trade Zone concept reached 276 million yuan, with 11 stocks experiencing net outflows, and 5 stocks seeing outflows exceeding 10 million yuan [2] Group 2 - HNA Technology had the largest net outflow of main funds at 113 million yuan, followed by Saixiang Technology and Jiuan Medical with net outflows of 107 million yuan and 2.52 million yuan respectively [2] - The stocks with the highest net inflows included Youfa Group, Tianjin Port, and Haitai Development, with inflows of 19.56 million yuan, 11.50 million yuan, and 5.79 million yuan respectively [3] - The trading performance of key stocks in the Tianjin Free Trade Zone concept showed significant volatility, with Saixiang Technology down by 10% and HNA Technology down by 5.92% [2][3]